Inventor · disambiguated record
Mark Rutz
Also filed as: RUTZ MARK · RUTZ MARK ANTHONY
12 granted patents·6 pending applications·73 citations·filing 2004–2021
91Inventor score
Top patents by PatentIndex Score
18 records- 0191US9522957B2Method of treating an inflammatory condition by administering toll-like 3 receptor antagonistsJANSSEN BIOTECH INC·Filed 2013·Granted Dec 20, 2016·10 cites·7 claims
- 0290US9481731B2Toll-like receptor 3 antagonistsJANSSEN BIOTECH INC·Filed 2013·Granted Nov 1, 2016·9 cites·10 claims
- 0390US9255153B2Polynucleotides encoding Toll-Like Receptor 3 antagonistsCUNNINGHAM MARK·Filed 2013·Granted Feb 9, 2016·10 cites·9 claims
- 0490US8519107B2IL-17A antibodiesALMAGRO JUAN CARLOS·Filed 2010·Granted Aug 27, 2013·24 cites·16 claims
- 0588US10106605B2Compositions and methods for antibodies targeting EpoNOVARTIS AG·Filed 2016·Granted Oct 23, 2018·6 cites·14 claims
- 0682US9238693B2Method of treating asthma or reducing inflammatory cell lung inflammation by administering toll-like receptor 3 antibodiesCUNNINGHAM MARK·Filed 2013·Granted Jan 19, 2016·3 cites·9 claims
- 0780US8409567B2Toll-like receptor 3 antagonistsCUNNINGHAM MARK·Filed 2009·Granted Apr 2, 2013·2 cites·17 claims
- 0878US9932404B2Methods of reducing clinical symptoms of viral infection by administering a toll-like receptor 3 antagonistJANSSEN BIOTECH INC·Filed 2016·Granted Apr 3, 2018·1 cites·18 claims
- 0978US8540986B2Toll-like receptor 3 antagonistsCUNNINGHAM MARK·Filed 2010·Granted Sep 24, 2013·2 cites·9 claims
- 1077US10385127B2Compositions and methods for antibodies targeting EPONOVARTIS AG·Filed 2018·Granted Aug 20, 2019·1 cites·19 claims
- 1175US9365646B2Compositions and methods for antibodies targeting EPOGHOSH JOY·Filed 2013·Granted Jun 14, 2016·3 cites·13 claims
- 1274US2021355206A1Compositions and methods for antibodies targeting epoNOVARTIS AG·Filed 2021·Application pending·0 cites
- 1373US8460659B2Toll-like receptor 3 antagonists for the treatment of metabolic and cardiovascular diseasesCUNNINGHAM MARK·Filed 2011·Granted Jun 11, 2013·2 cites·5 claims
- 1466US2018179294A1Toll-like receptor 3 antagonistsJANSSEN BIOTECH INC·Filed 2018·Application pending·0 cites
- 1564US2020048341A1Compositions and methods for antibodies targeting epoNOVARTIS AG·Filed 2019·Application pending·0 cites
- 1655US2005100983A1Cell-free methods for identifying compounds that affect toll-like receptor 9 (TLR9) signalingUNIV MUENCHEN TECH·Filed 2004·Application pending·0 cites
- 1749US2014017250A1Toll-Like Receptor 3 Antagonists for the Treatment of Metabolic and Cardiovascular DiseasesCUNNINGHAM MARK·Filed 2013·Application pending·0 cites
- 1841US2013090457A1Toll-Like Receptor 3 Antagonists for the Treatment of Metabolic and Cardiovascular DiseasesCUNNINGHAM MARK·Filed 2012·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Mark Rutz files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →